In recent years, the increased incidence of differentiated thyroid cancers has largely been attributed to microcarcinomas.
The aim of this study was to evaluate the impact of adjuvant radioactive iodine (RAI) therapy on recurrence in patients with multifocal papillary thyroid carcinoma (PTC) ≤ 1 cm.
